4d-e), suggesting that starting to add rapamycin on day 4 post-anti-CD3/CD28 beads activation did not prevent activated CAR T cells from dividing
To further confirm this potential shift in the conformational equilibrium, we collected a second cryo-EM dataset for Cagri-CTR ( N = 2) from a separate protein purification
188 , 41834189 (2006) Bierbaum, G
We further examined whether ASK1 signalling affects the LD growth process
Acute injury protocol: Weeks 12: 500mcg each peptide twice daily, localized + systemic Weeks 34: 500mcg each peptide once daily, systemic Weeks 56: 250mcg each peptide once daily, systemic Total duration: 6 weeks Chronic condition protocol: Weeks 14: 500mcg each peptide once daily Weeks 58: 250500mcg each peptide once daily (based on response) Weeks 912: 250mcg each peptide once daily or every other day Total duration: 12 weeks Post-surgical protocol: Days 17: 500mcg each peptide twice daily Weeks 24: 500mcg each peptide once daily Weeks 56: 250mcg each peptide once daily Total duration: 6 weeks Monitoring and Adjustments Protocols should track the following
This unique property sets it apart from most therapeutic peptides and expands potential administration routes